IL317872A - Process and intermediates useful for preparing nirmatrelvir - Google Patents

Process and intermediates useful for preparing nirmatrelvir

Info

Publication number
IL317872A
IL317872A IL317872A IL31787224A IL317872A IL 317872 A IL317872 A IL 317872A IL 317872 A IL317872 A IL 317872A IL 31787224 A IL31787224 A IL 31787224A IL 317872 A IL317872 A IL 317872A
Authority
IL
Israel
Prior art keywords
nirmatrelvir
preparing
intermediates useful
intermediates
useful
Prior art date
Application number
IL317872A
Other languages
Hebrew (he)
Inventor
Christophe Philippe Allais
Nga My Do
Samir Ashok Kulkarni
David William Place
John Anthony Ragan
Emma Leigh Rincon
Rodney Matthew Weekly
Original Assignee
Pfizer
Christophe Philippe Allais
Nga My Do
Samir Ashok Kulkarni
David William Place
John Anthony Ragan
Emma Leigh Rincon
Rodney Matthew Weekly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Christophe Philippe Allais, Nga My Do, Samir Ashok Kulkarni, David William Place, John Anthony Ragan, Emma Leigh Rincon, Rodney Matthew Weekly filed Critical Pfizer
Publication of IL317872A publication Critical patent/IL317872A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IL317872A 2022-06-30 2023-06-27 Process and intermediates useful for preparing nirmatrelvir IL317872A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263367365P 2022-06-30 2022-06-30
PCT/IB2023/056621 WO2024003737A1 (en) 2022-06-30 2023-06-27 Process and intermediates useful for preparing nirmatrelvir

Publications (1)

Publication Number Publication Date
IL317872A true IL317872A (en) 2025-02-01

Family

ID=87378150

Family Applications (1)

Application Number Title Priority Date Filing Date
IL317872A IL317872A (en) 2022-06-30 2023-06-27 Process and intermediates useful for preparing nirmatrelvir

Country Status (9)

Country Link
US (1) US20250230150A1 (en)
EP (1) EP4547661A1 (en)
JP (1) JP2025525405A (en)
KR (1) KR20250029937A (en)
CN (1) CN119677728A (en)
CA (1) CA3260504A1 (en)
IL (1) IL317872A (en)
TW (1) TWI870909B (en)
WO (1) WO2024003737A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
IN202141055178A (en) * 2021-11-29 2023-06-02 Aurobindo Pharma Ltd
CN114031543A (en) * 2021-12-21 2022-02-11 上海朴颐化学科技有限公司 Preparation method of intermediate of palovaried
CN114409727A (en) * 2021-12-28 2022-04-29 苏州康纯医药科技有限公司 Preparation method of anti-coronavirus 3CLPRO inhibitor
CN114213275B (en) * 2021-12-31 2023-08-04 戊言医药科技(上海)有限公司 Intermediate product for synthesizing Pa Luo Weide and preparation method
TW202334123A (en) * 2021-12-31 2023-09-01 大陸商蘇州愛科百發生物醫藥技術有限公司 Compounds, conjugates and methods thereof for preventing and treating coronavirus infection
CN114605492A (en) * 2022-04-02 2022-06-10 弈柯莱生物科技(上海)股份有限公司 Preparation method of intermediate of palovaried

Also Published As

Publication number Publication date
US20250230150A1 (en) 2025-07-17
EP4547661A1 (en) 2025-05-07
JP2025525405A (en) 2025-08-05
CA3260504A1 (en) 2024-01-04
WO2024003737A1 (en) 2024-01-04
TWI870909B (en) 2025-01-21
TW202408486A (en) 2024-03-01
CN119677728A (en) 2025-03-21
KR20250029937A (en) 2025-03-05

Similar Documents

Publication Publication Date Title
IL316667A (en) Process for preparing relugolix and intermediates thereof
IL310930A (en) Process for synthesizing naphthyridine derivatives and intermediates thereof
IL321413A (en) Processes and intermediates for preparing tirzepatide
GB202301309D0 (en) Process
GB202217102D0 (en) Process
GB202210681D0 (en) Process
GB202301443D0 (en) Process
GB202210917D0 (en) Process
EP4031533A4 (en) Process for preparing elagolix sodium and intermediates thereof
GB202219669D0 (en) Processes and intermediates for synthesising opicapone
ZA202213744B (en) Method for preparing tadalafil and intermediates thereof
IL319923A (en) Method of preparing maribavir
GB202303138D0 (en) Novel culture method
CA3260504A1 (en) Process and intermediates useful for preparing nirmatrelvir
GB202208517D0 (en) New process
GB202210937D0 (en) Process
GB202205978D0 (en) Process
HK40111035A (en) Process and intermediates for preparing baricitinib
CA3278598A1 (en) Processes and intermediates for preparing tirzepatide
HUP2100077A1 (en) Process for the preparation of avapritinib and intermediates for the process
IL321701A (en) Intermediates of sonrotoclax and the method of preparing the same
GB202306850D0 (en) Fermentation process
GB202213780D0 (en) Novel compounds and process
IL318203A (en) Process for preparing substituted benzamides
IL318599A (en) Continuous process